Repaglinide
- Product NDC
- 71335-2554
- 11-digit product format
- 713352554
- Labeler code
- 71335
- Product ID
- 71335-2554_0b66565e-c13c-4b45-82d4-72df4696fc70
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA207209
- Marketing category
- ANDA
- Marketing start
- 2023-03-22
- Substance
- REPAGLINIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200257 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-2554-1 | Repaglinide | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 71335-2554-2 | Repaglinide | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-2554 | REPAGLINIDE TABLET [BRYANT RANCH PREPACK] | 1 | Current NDC, 2 package rows | 20250125_9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2554-1 | 71335255401 | 30 TABLET in 1 BOTTLE (71335-2554-1) | 30 tablet | 2025-01-23 | No | No | Historical |
| 71335-2554-2 | 71335255402 | 90 TABLET in 1 BOTTLE (71335-2554-2) | 90 tablet | 2025-01-23 | No | No | Historical |